Evonik Industries (FRA:EVK) has been given a €36.00 ($44.44) price objective by equities researchers at Citigroup in a report issued on Wednesday. The firm presently has a “buy” rating on the stock. Citigroup’s target price would suggest a potential upside of 25.92% from the company’s current price.
Several other brokerages have also weighed in on EVK. UBS set a €27.00 ($33.33) price objective on Evonik Industries and gave the company a “sell” rating in a report on Monday, January 8th. DZ Bank reissued a “buy” rating on shares of Evonik Industries in a report on Wednesday, February 14th. Baader Bank set a €38.00 ($46.91) price objective on Evonik Industries and gave the company a “buy” rating in a report on Thursday, December 14th. Nord/LB set a €30.00 ($37.04) price objective on Evonik Industries and gave the company a “neutral” rating in a report on Tuesday, March 6th. Finally, JPMorgan Chase & Co. set a €25.00 ($30.86) price objective on Evonik Industries and gave the company a “sell” rating in a report on Tuesday, March 6th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the stock. Evonik Industries has an average rating of “Hold” and an average price target of €33.80 ($41.73).
Shares of EVK stock opened at €28.59 ($35.30) on Wednesday. The company has a market capitalization of $13,290.00 and a P/E ratio of 18.56. Evonik Industries has a 52-week low of €26.78 ($33.06) and a 52-week high of €32.97 ($40.70).
ILLEGAL ACTIVITY WARNING: “Evonik Industries (EVK) PT Set at €36.00 by Citigroup” was originally published by Transcript Daily and is the property of of Transcript Daily. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://transcriptdaily.com/2018/03/21/evonik-industries-evk-pt-set-at-36-00-by-citigroup.html.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.